$DGX with a bullish outlook following its earnings #StocksThe PEAD projected a bullish outlook for NYSE:DGX after a positive under reaction following its earnings release placing the stock in drift A with an expected accuracy of 57.14%.
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
7.40 EUR
836.54 M EUR
9.54 B EUR
111.08 M
About Quest Diagnostics Incorporated
Sector
Industry
CEO
James E. Davis
Website
Headquarters
Secaucus
Founded
1967
FIGI
BBG01TNY32T6
Quest Diagnostics, Inc. engages in the provision of diagnostic testing, information, and services. It operates through the Diagnostic Information Services (DIS) and All Other segments. The DIS segment offers diagnostic information services to physicians, hospitals, patients, and consumers. The All Other segment consists of risk assessment services and healthcare information technology. The company was founded in 1967 and is headquartered in Secaucus, NJ.
Is this a double bottom?I don't know either. But I've placed a stop buy order above the price - if it breaksout to the upside, I'll enter long.
Quest Diagnostics // Buy Future Dip Notes on how I personally use my charts/NFA:
Each level L1-L3 and TP1-TP3 (Or S1-S3) has a deployment percentage. The idea is to flag these levels so I can buy 11% at L1 , 28% at L2 and if L3 deploy 61% of assigned dry powder. The same in reverse goes for TP. TP1: 61%, TP2:28% and TP3:11%. If chart
DGX Quest Diagnostics is an American clinical laboratory. A Fortune 500 company, Quest operates in the United States, Puerto Rico, Mexico, and Brazil. Quest also maintains collaborative agreements with various hospitals and clinics across the globe.
DGX PUT ideaDGX is :
Current price: 139,91
1- in descending triangle
2- Low volume
3- SMA 200 reacts as resistance along with the descending triangle
4- EBITDA in decline except for Q1 2023
=> Put options for January 2024 open. no SL.
Counter trade:
1- Analysts target: 145
2- OBV/AD are trending higher
3- PE
$DGX with a neutral outlook following its earnings #StocksThe PEAD projected a neutral outlook for $DGX after a Negative over reaction following its earnings release placing the stock in drift C with an expected accuracy of 71.43%.
$DGX with a Bullish outlook following its earnings #Stocks The PEAD projected a Bullish outlook for $DGX after a Positive Under reaction following its earnings release placing the stock in drift A with an expected accuracy of 25%.
Quest Diagnostic Incorporated – Rare Stock with 30% Upside OpporIf you like this idea, please don’t forget to Boost it.
Fundamental Indicators:
Sector – Healthcare
US Business Cycle Stage – late cycle, when this sector is favourable
Revenue – consistently growing for the past 5 years, with 9% average annual rate
Profits – explosive growth until
180 day MA ResistanceNYSE:DGX
Anticipating a pull back after the resistance shown at the 180 day MA on 3/18/22.
See all ideas
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
US74834LAY6
QUEST DIAGNOSTICS 15/45Yield to maturity
6.52%
Maturity date
Mar 30, 2045
DGX.GL
Quest Diagnostics Incorporated 5.75% 30-JAN-2040Yield to maturity
5.88%
Maturity date
Jan 30, 2040
DGX.GJ
Quest Diagnostics Incorporated 6.95% 01-JUL-2037Yield to maturity
5.30%
Maturity date
Jul 1, 2037
DGX5874569
Quest Diagnostics Incorporated 5.0% 15-DEC-2034Yield to maturity
5.27%
Maturity date
Dec 15, 2034
DGX5678099
Quest Diagnostics Incorporated 6.4% 30-NOV-2033Yield to maturity
5.07%
Maturity date
Nov 30, 2033
DGX4986719
Quest Diagnostics Incorporated 2.8% 30-JUN-2031Yield to maturity
5.04%
Maturity date
Jun 30, 2031
DGX4923784
Quest Diagnostics Incorporated 2.95% 30-JUN-2030Yield to maturity
4.92%
Maturity date
Jun 30, 2030
DGX4807226
Quest Diagnostics Incorporated 4.2% 30-JUN-2029Yield to maturity
4.66%
Maturity date
Jun 30, 2029
DGX5874568
Quest Diagnostics Incorporated 4.625% 15-DEC-2029Yield to maturity
4.66%
Maturity date
Dec 15, 2029
DGX4366387
Quest Diagnostics Incorporated 3.45% 01-JUN-2026Yield to maturity
4.48%
Maturity date
Jun 1, 2026
DGX5874579
Quest Diagnostics Incorporated 4.6% 15-DEC-2027Yield to maturity
4.38%
Maturity date
Dec 15, 2027
See all 1QDX bonds
Related stocks
Frequently Asked Questions
The current price of 1QDX is 155.40 EUR — it has increased by 0.93% in the past 24 hours. Watch QUEST DIAGNOSTIC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on MIL exchange QUEST DIAGNOSTIC stocks are traded under the ticker 1QDX.
1QDX stock has risen by 1.74% compared to the previous week, the month change is a 1.74% rise, over the last year QUEST DIAGNOSTIC has showed a 0.39% increase.
We've gathered analysts' opinions on QUEST DIAGNOSTIC future price: according to them, 1QDX price has a max estimate of 176.77 EUR and a min estimate of 141.42 EUR. Watch 1QDX chart and read a more detailed QUEST DIAGNOSTIC stock forecast: see what analysts think of QUEST DIAGNOSTIC and suggest that you do with its stocks.
1QDX reached its all-time high on Apr 30, 2025 with the price of 156.15 EUR, and its all-time low was 154.80 EUR and was reached on Apr 25, 2025. View more price dynamics on 1QDX chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
1QDX stock is 1.35% volatile and has beta coefficient of 0.27. Track QUEST DIAGNOSTIC stock price on the chart and check out the list of the most volatile stocks — is QUEST DIAGNOSTIC there?
Today QUEST DIAGNOSTIC has the market capitalization of 17.52 B, it has increased by 2.27% over the last week.
Yes, you can track QUEST DIAGNOSTIC financials in yearly and quarterly reports right on TradingView.
QUEST DIAGNOSTIC is going to release the next earnings report on Jul 23, 2025. Keep track of upcoming events with our Earnings Calendar.
1QDX earnings for the last quarter are 2.04 EUR per share, whereas the estimation was 1.99 EUR resulting in a 2.72% surprise. The estimated earnings for the next quarter are 2.27 EUR per share. See more details about QUEST DIAGNOSTIC earnings.
QUEST DIAGNOSTIC revenue for the last quarter amounts to 2.45 B EUR, despite the estimated figure of 2.43 B EUR. In the next quarter, revenue is expected to reach 2.41 B EUR.
1QDX net income for the last quarter is 202.43 M EUR, while the quarter before that showed 212.52 M EUR of net income which accounts for −4.75% change. Track more QUEST DIAGNOSTIC financial stats to get the full picture.
Yes, 1QDX dividends are paid quarterly. The last dividend per share was 0.73 EUR. As of today, Dividend Yield (TTM)% is 1.72%. Tracking QUEST DIAGNOSTIC dividends might help you take more informed decisions.
QUEST DIAGNOSTIC dividend yield was 1.99% in 2024, and payout ratio reached 39.15%. The year before the numbers were 2.06% and 37.76% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of May 7, 2025, the company has 56 K employees. See our rating of the largest employees — is QUEST DIAGNOSTIC on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. QUEST DIAGNOSTIC EBITDA is 1.83 B EUR, and current EBITDA margin is 19.33%. See more stats in QUEST DIAGNOSTIC financial statements.
Like other stocks, 1QDX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade QUEST DIAGNOSTIC stock right from TradingView charts — choose your broker and connect to your account.